64
Ttbio Corp.
6493.TWO · TWO
$34.95 +0.14% (+$0.05)
1M -6.40%
Market Cap $1.05B
P/E Ratio -
Div. Yield -
ROE 6.55%
Bulios Fair Price
$35.84
2.5% upside
Current Price
$34.95
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6493.TWO is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
29 /100
Expensive P/S 2.64x
P/B 2.95x
EV/EBITDA 79.32x
Growth
19 /100
Declining Book val. growth 3.42%
Rev. growth 1.62%
FCF growth N/A
Profitability
2 /100
Weak Net margin 5.34%
Op. margin 5.32%
FCF margin 12.29%
Quality
8 /100
Poor ROE 6.55%
ROA 3.42%
Asset turnover 0.64x
Debt
40 /100
Moderate Current ratio 2.37x
Int. coverage -3.89x
Net debt/EBITDA 8.20x
Stability
37 /100
Moderate Rev. volatility 26.02%
EPS volatility 431.20%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6493.TWO
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Sheng Jie Su
Employees
138
Headquarters
Taichung